Early Identification of Metabolic Syndrome in Adults of Jiaxing, China: Utilizing a Multifactor Logistic Regression Model
Shiyu Hu,Wenyu Chen,Xiaoli Tan,Ye Zhang,Jiaye Wang,Lifang Huang,Jianwen Duan
DOI: https://doi.org/10.2147/dmso.s468718
2024-08-24
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Shiyu Hu, 1, 2, &ast Wenyu Chen, 2, &ast Xiaoli Tan, 2, &ast Ye Zhang, 1, 2 Jiaye Wang, 1, 2 Lifang Huang, 3 Jianwen Duan 4 1 Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Respiratory Medicine, The Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, People's Republic of China; 3 Health Management Center, The Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, People's Republic of China; 4 Department of Hepatobiliary Surgery, Quzhou People's Hospital, Quzhou, Zhejiang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lifang Huang, Health Management Center, The Affiliated Hospital of Jiaxing University, No. 1882, Zhonghuan South Road, Nanhu District, Jiaxing, Zhejiang, 314001, People's Republic of China, Email Jianwen Duan, Department of Hepatobiliary Surgery, Quzhou People's Hospital, No. 2, Zhongloudi, Quzhou, Zhejiang, 324000, People's Republic of China, Email Purpose: The purpose of this study is to develop and validate a clinical prediction model for diagnosing Metabolic Syndrome (MetS) based on indicators associated with its occurrence. Patients and Methods: This study included a total of 26,637 individuals who underwent health examinations at the Jiaxing First Hospital Health Examination Center from January 19, 2022, to December 31, 2022. They were randomly divided into training (n = 18645) and validation (n = 7992) sets in a 7:3 ratio. Firstly, the Least Absolute Shrinkage and Selection Operator (LASSO) regression algorithm was employed for variable selection. Subsequently, a multifactor Logistic regression analysis was conducted to establish the predictive model, accompanied by nomograms. Thirdly, model validation was performed using Receiver Operating Characteristic (ROC) curves, Harrell's concordance index (C-index), calibration plots, and Decision Curve Analysis (DCA), followed by internal validation. Results: In this study, six predictive indicators were selected, including Body Mass Index, Triglycerides, Blood Pressure, High-Density Lipoprotein Cholesterol, Low-Density Lipoprotein Cholesterol, and Fasting Blood Glucose. The model demonstrated excellent predictive performance, with an AUC of 0.978 (0.976– 0.980) for the training set and 0.977 (0.974– 0.980) for the validation set in the nomogram. Calibration curves indicated that the model possessed good calibration ability (Training set: Emax 0.081, Eavg 0.005, P = 0.580; Validation set: Emax 0.062, Eavg 0.007, P = 0.829). Furthermore, decision curve analysis suggested that applying the nomogram for diagnosis is more beneficial when the threshold probability of MetS is less than 89%, compared to either treating-all or treating-none at all. Conclusion: We developed and validated a nomogram based on MetS risk factors, which can effectively predict the occurrence of MetS. The proposed nomogram demonstrates significant discriminative ability and clinical applicability. It can be utilized to identify variables and risk factors for diagnosing MetS at an early stage. Keywords: metabolic syndrome, risk factors, nomogram, prediction In 1988, Reaven first described Metabolic Syndrome (MetS) as Syndrome X, representing a clinical metabolic disorder characterized by a collection of risk factors. These factors include hypertension, insulin resistance (IR), elevated blood glucose, high levels of low-density lipoprotein cholesterol (LDL-C), and increased triglycerides (TG). 1 MetS is a multifaceted pathophysiological condition that may arise from an imbalance between energy intake and expenditure. It can also be influenced by individual genetics, unhealthy lifestyle, as well as other factors including food quality and composition. 2 IR is one of the core characteristics of this disease. A series of metabolic disorders triggered by IR, including hyperglycemia, hyperinsulinemia, and lipid metabolism abnormalities, are significant contributors to MetS. The abnormal accumulation of adipose tissue, especially the increase in visceral fat, leads to obesity, which is not only a result of IR but also one of its causes. Additionally, chronic low-grade inflammation and oxidative stress play important roles in the occurrence and progression of MetS. 3–5 Regarding MetS, we do not have direct global prevalence data. Nevertheless, the occurrence of MetS is roughly threefold higher compared to diabetes (DM), 6 with an estimated 529 million diabetes patients in 2021, 7 it is estimated that globally about 1.6 bill -Abstract Truncated-
endocrinology & metabolism